Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells
- 1 November 2002
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 137 (6) , 910-918
- https://doi.org/10.1038/sj.bjp.0704926
Abstract
1. The extraneuronal monoamine transporter from rat (EMTr) was heterologously expressed by stable transfection in human embryonic kidney 293 cells and characterized in radiotracer experiments. 2. EMTr-mediated uptake of 1-methyl-4-phenylpyridinium (MPP(+)) was saturable, with a K(m) of 151 micro mol l(-1) and V(max) of 7.5 nmol min(-1) mg protein(-1). 3. Compared to the human orthologue EMTh (gene symbol SLC22A3), EMTr was about two orders of magnitude more resistant to most inhibitors, including disprocynium24 and corticosterone. 4. Strikingly, inhibitors and substrates at low concentration stimulated EMTr-mediated transport above control level with MPP(+) and noradrenaline as substrate, but not with cimetidine. Results were confirmed with EMT from mouse. 5. With different IC(50)-values for different substrates, the standard method to calculate K(i)-values is not applicable. 6. Our experiments suggest that activation is not caused by changes in membrane potential or trans-stimulation. Since the extent of activation depends markedly on the chemical structure of the monitored substrate, involvement of a receptor-mediated signalling pathway or recruitment of transporter reserve are implausible. 7. To explain activation, we present a kinetic model which assumes two binding sites for substrate or inhibitor per transporter entity, possibly resulting from the assembly of homodimers. 8. Activation explains previous reports about inhibitor-insensitive catecholamine transport in rat brain. 9. We speculate that activation may serve to keep the transporter working for specific substrates in the face of inhibitors.Keywords
This publication has 42 references indexed in Scilit:
- Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) GeneMolecular and Cellular Biology, 2001
- Impaired Activity of the Extraneuronal Monoamine Transporter System Known as Uptake-2 in Orct3/Slc22a3-Deficient MiceMolecular and Cellular Biology, 2001
- Cloning of the Mouse and Human Solute Carrier 22a3 (Slc22a3/SLC22A3) Identifies a Conserved Cluster of Three Organic Cation Transporters on Mouse Chromosome 17 and Human 6q26–q27Genomics, 1999
- Catecholamine transport by the organic cation transporter type 1 (OCT1)British Journal of Pharmacology, 1998
- Primary Structure and Functional Expression of the Apical Organic Cation Transporter from Kidney Epithelial LLC-PK1CellsPublished by Elsevier ,1997
- cDNA Cloning and Functional Expression of a Novel Rat Kidney Organic Cation Transporter, OCT2Biochemical and Biophysical Research Communications, 1996
- Drug excretion mediated by a new prototype of polyspecific transporterNature, 1994
- Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline-transport inhibitors: synthesis, detection, and biological activityJournal of Medicinal Chemistry, 1993
- Effects on transport of rapidly penetrating, competing substrates: Activation and inhibition of the choline carrier in erythrocytes by imidazoleThe Journal of Membrane Biology, 1987
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973